Benzinga | Nov 5, 2021 11:56AM EDT

William Blair Downgrades Calithera Biosciences to Market Perform

William Blair analyst Matt Phipps downgrades Calithera Biosciences (NASDAQ:CALA) from Outperform to Market Perform.